Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy

PURPOSE: Androgen receptor (AR) signaling is important in prostate cancer progression, and therapies that target this pathway have been the mainstay of treatment for advanced disease for over 70 years. Tumors eventually progress despite castration through a number of well-characterized mechanisms; h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Cmero, Marek, Kurganovs, Natalie J., Stuchbery, Ryan, McCoy, Patrick, Grima, Corrina, Ngyuen, Anne, Chow, Ken, Mangiola, Stefano, Macintyre, Geoff, Howard, Nicholas, Kerger, Michael, Dundee, Philip, Ruljancich, Paul, Clarke, David, Grummet, Jeremy, Peters, Justin S., Costello, Anthony J., Norden, Sam, Ryan, Andrew, Parente, Phillip, Hovens, Christopher M., Corcoran, Niall M.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238292/
https://ncbi.nlm.nih.gov/pubmed/34322653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados